Directory of On-going Research in Cancer Epidemiology 1994 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Directory of On-going Research in Cancer Epidemiology 1994 PDF full book. Access full book title Directory of On-going Research in Cancer Epidemiology 1994 by E. Démaret. Download full books in PDF and EPUB format.
Author: E. Démaret
Publisher:
ISBN: 9789283221302
Category : Medical
Languages : en
Pages : 830
Get Book Here
Book Description
This directory is an annual compendium of current research in epidemiology. The 1994 edition (17th in the series) contains abstracts of the 1246 projects being carried out in over 80 countries, and reflects the huge range of epidemiological research into the distribution, causes, and prevention of cancer around the world. Each project is indexed in up to eight separate indexes, enabling rapid searches for current studies fitting almost any description. The eight indexes are: name of investigator(s); keywords; cancer site(s); study type (cohort, case-control, etc.); country; chemical exposure; occupational exposure; and cancer registry. The Directory also includes comprehensive lists of 261 population-based cancer registries and over 300 biological material banks, all available for collaboration in epidemiological research. The addresses, telephone and telex numbers of nearly 1000 principal investigators is provided to improve contact between research workers.
Author: E. Démaret
Publisher:
ISBN: 9789283221302
Category : Medical
Languages : en
Pages : 830
Get Book Here
Book Description
This directory is an annual compendium of current research in epidemiology. The 1994 edition (17th in the series) contains abstracts of the 1246 projects being carried out in over 80 countries, and reflects the huge range of epidemiological research into the distribution, causes, and prevention of cancer around the world. Each project is indexed in up to eight separate indexes, enabling rapid searches for current studies fitting almost any description. The eight indexes are: name of investigator(s); keywords; cancer site(s); study type (cohort, case-control, etc.); country; chemical exposure; occupational exposure; and cancer registry. The Directory also includes comprehensive lists of 261 population-based cancer registries and over 300 biological material banks, all available for collaboration in epidemiological research. The addresses, telephone and telex numbers of nearly 1000 principal investigators is provided to improve contact between research workers.
Author: C. S. Muir
Publisher:
ISBN: 9789283211808
Category : Language Arts & Disciplines
Languages : en
Pages : 856
Get Book Here
Book Description
This new directory is a list of 1,352 projects being undertaken in 71 countries, particularly the U.S. and the U.K. It includes the first projects on molecular epidemiology as well as work done in mutation epidemiology. It also lists biological material banks and their holdings, population-based cancer registries, and tabulations of the funds expended by various institutes and registries.
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Publisher: World Health Organization
ISBN: 9283212894
Category : Medical
Languages : en
Pages : 642
Get Book Here
Book Description
This eighty-ninth volume of the IARC Monographs is the third and last of a series on tobacco-related agents. Volume 83 reported on the carcinogenicity of tobacco smoke and involuntary smoking (second-hand smoke or environmental tobacco smoke) (IARC 2004a). Volume 85 summarized the evidence on the carcinogenic risk of chewing betel quid with and without tobacco (IARC 2004b). That volume explored the variety of products chewed in South Asia and other parts of the word that contain areca nut in combination with other ingredients, often including tobacco. In this eighty-ninth volume, the carcinogenic risks associated with the use of smokeless tobacco, including chewing tobacco and snuff, are considered in a first monograph. The second monograph reviews some tobacco-specific nitrosamines. These agents were evaluated earlier in Volume 37 of the Monographs (IARC 1985) and information gathered since that time has been summarized and evaluated.
Author:
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 854
Get Book Here
Book Description
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Publisher: World Health Organization
ISBN: 9283212800
Category : Medical
Languages : en
Pages : 446
Get Book Here
Book Description
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 19-26 June 2001.
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Publisher: World Health Organization
ISBN: 9283212827
Category : Medical
Languages : en
Pages : 602
Get Book Here
Book Description
This publication represents the views and expert opinions of an IARC Working Group which met in Lyon, 12-19 February 2002.
Author: Kirk T. Kitchin
Publisher: CRC Press
ISBN: 1000105466
Category : Science
Languages : en
Pages : 918
Get Book Here
Book Description
Offers comprehensive coverage of currently available cancer predictors, the most recent research on carcinogenicity, and the design and interpretation of carcinogenicity experiments. Presents mouse, rat, and human carcinogenicity data for the liver, kidney, breast, cervix, prostate, hematopoietic system, colon, skin, urinary bladder, mouth, stomach, thyroid, and pancreas.
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Publisher: World Health Organization
ISBN: 9283212797
Category : Health & Fitness
Languages : en
Pages : 774
Get Book Here
Book Description
This publication represents the views and expert opinions of an IARC Working Group which met in Lyon, 10-17 October 2000.
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Publisher: World Health Organization
ISBN: 9283212770
Category : Medical
Languages : en
Pages : 574
Get Book Here
Book Description
This publication represents the views and expert opinion of an IARC Working Group which met in Lyon, 15-22 February 2000.
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Meeting
Publisher: World Health Organization
ISBN: 9283212908
Category : Medical
Languages : en
Pages : 690
Get Book Here
Book Description
This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to Humansconsiders human papillomaviruses (HPVs) which were evaluated by a previous Working Group (IARC, 1995). The monograph in the present volume incorporates new data that have become available during the past decade. HPVs represent the most common infectious agents that are transmitted sexually throughout the world; the major risk factors are behaviors associated with sexual activity. Although most infections are asymptomatic and are cleared within a period of 2 years, genital HPV infection can lead to clinical disease, including anogenital warts, cervical neoplasia, cervical cancer and other anogenital cancers. The risk for persistence of infection and progression of the more than 40 genital HPV types to grade 3 cervical intraepithelial neoplasia (CIN3) and cancer differs widely. Persistent infection with carcinogenic HPVs occurs in virtually all cases of cervical cancer. Previous evaluations of HPVs have classified types 16 and 18 as carcinogenic to humans (group 1), types 31 and 33 as probably carcinogenic to humans (Group 2A) and some types other than 16, 18, 31 and 33 as possibly carcinogenic to humans (Group 2B). At that time, the evaluation of types 16 and 18 was based on the strong association between infection with these HPVs and cervical cancer. For types 31 and 33, the association was less strong. The new epidemiological data reviewed in the present volume strongly support and further confirm the previous evaluation of types 16 and 18, and provide new evidence for other HPVs. This information, which includes strong evidence of carcinogenicity at sites other than the cervix, supports new evaluations for several other HPV types in addition to those mentioned above. Since the Working Group was convened in 2005, important innovations in HPV prophylaxis have occurred and these needed to be included in this volume. To date two prophylactic vaccines have been developed and used in large multicentric trials. This prophylactic vaccination is expected to reduce the incidence of HPV-related genital diseases. However, the benefits of prophylactic vaccines in a broad public health perspective will be achieved only if such vaccines can be provided to those groups of women for whom access to cervical cancer screening services is most problematic. Therefore, the development of second-generation vaccines that are expected to be cheaper, easier to deliver and to provide T-cell response against pre-existing HPV infections is highly desirable.
